Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Drug Discovery Informatics Market, by Application
1.4.2 Europe Drug Discovery Informatics Market, by Function
1.4.3 Europe Drug Discovery Informatics Market, by End User
1.4.4 Europe Drug Discovery Informatics Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2020-2024)
4.3.2 Key Strategic Move: (Mergers & Acquisition: 2020, Sep – 2023, Dec) Leading Players
4.4 Porter’s Five Forces Analysis
Chapter 5. Europe Drug Discovery Informatics Market by Application
5.1 Europe Drug Discovery Market by Country
5.2 Europe Drug Development Market by Country
Chapter 6. Europe Drug Discovery Informatics Market by Function
6.1 Europe Sequencing & Target Data Analysis Market by Country
6.2 Europe Molecular Modelling Market by Country
6.3 Europe Library & Database Preparation Market by Country
6.4 Europe Docking Market by Country
6.5 Europe Others Market by Country
Chapter 7. Europe Drug Discovery Informatics Market by End User
7.1 Europe Pharmaceutical Companies Market by Country
7.2 Europe Biotechnology Companies Market by Country
7.3 Europe Contract Research Organizations Market by Country
7.4 Europe Others Market by Country
Chapter 8. Europe Drug Discovery Informatics Market by Country
8.1 Germany Drug Discovery Informatics Market
8.1.1 Germany Drug Discovery Informatics Market by Application
8.1.2 Germany Drug Discovery Informatics Market by Function
8.1.3 Germany Drug Discovery Informatics Market by End User
8.2 UK Drug Discovery Informatics Market
8.2.1 UK Drug Discovery Informatics Market by Application
8.2.2 UK Drug Discovery Informatics Market by Function
8.2.3 UK Drug Discovery Informatics Market by End User
8.3 France Drug Discovery Informatics Market
8.3.1 France Drug Discovery Informatics Market by Application
8.3.2 France Drug Discovery Informatics Market by Function
8.3.3 France Drug Discovery Informatics Market by End User
8.4 Russia Drug Discovery Informatics Market
8.4.1 Russia Drug Discovery Informatics Market by Application
8.4.2 Russia Drug Discovery Informatics Market by Function
8.4.3 Russia Drug Discovery Informatics Market by End User
8.5 Spain Drug Discovery Informatics Market
8.5.1 Spain Drug Discovery Informatics Market by Application
8.5.2 Spain Drug Discovery Informatics Market by Function
8.5.3 Spain Drug Discovery Informatics Market by End User
8.6 Italy Drug Discovery Informatics Market
8.6.1 Italy Drug Discovery Informatics Market by Application
8.6.2 Italy Drug Discovery Informatics Market by Function
8.6.3 Italy Drug Discovery Informatics Market by End User
8.7 Rest of Europe Drug Discovery Informatics Market
8.7.1 Rest of Europe Drug Discovery Informatics Market by Application
8.7.2 Rest of Europe Drug Discovery Informatics Market by Function
8.7.3 Rest of Europe Drug Discovery Informatics Market by End User
Chapter 9. Company Profiles
9.1 Oracle Corporation
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 Accenture PLC
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Acquisition and Mergers:
9.2.6 SWOT Analysis
9.3 Thermo Fisher Scientific, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.5.2 Product Launches and Product Expansions:
9.3.5.3 Acquisition and Mergers:
9.3.6 SWOT Analysis
9.4 Boehringer Ingelheim International GmbH
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional & Segmental Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.6 SWOT Analysis
9.5 Infosys Limited
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Acquisition and Mergers:
9.5.6 SWOT Analysis
9.6 Charles River Laboratories International, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Recent strategies and developments:
9.6.4.1 Partnerships, Collaborations, and Agreements:
9.6.4.2 Acquisition and Mergers:
9.6.5 SWOT Analysis
9.7 Agilent Technologies, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.5.2 Acquisition and Mergers:
9.7.6 SWOT Analysis
9.8 Illumina, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segment and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 Recent strategies and developments:
9.8.5.1 Partnerships, Collaborations, and Agreements:
9.8.5.2 Acquisition and Mergers:
9.8.6 SWOT Analysis
9.9 Certara, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional Analysis
9.9.4 Research & Development Expenses
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.5.2 Product Launches and Product Expansions:
9.9.5.3 Acquisition and Mergers:
9.9.6 SWOT Analysis
9.10. Jubilant Pharmova Limited
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 SWOT Analysis
Unique Offerings 